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ABSTRACT 
 
Herein we have explored two practical aspects of cryopreserving cultured mammalian cells during routine laboratory maintenance. First, 
we have examined the possibility of using a serum-free, hence more affordable, cryopreservative. Using five mammalian lines (Crandell 
Feline Kidney, MCF7, A72, WI 38 and NB324K), we found that the serum-free alternative preserves nearly as efficiently as the serum-
containing preservatives. Second, we compared cryostorage of those cells in suspended versus a pellet form using both aforementioned 
cryopreservatives. Under our conditions, cells were in general recovered equally well in a suspended versus a pellet form. 
 
 
INTRODUCTION 
 
The primary causes of cell death during cryopreservation appear 
to be formation of both ice crystals and osmotic gradients across 
the cell membrane (1-5). As such, cryopreservatives have been 
employed to retain viability during the freezing and thawing 
processes. Although numerous agents have been observed to 
promote cell viability during the freezing process (6), historically, 
dimethyl sulfoxide (DMSO) and glycerol have been used as 
preservatives for storing cells in a frozen state (1-2, 4, 6). During 
routine maintenance in many cell biology, virology, and 
molecular biology laboratories, mammalian cell lines are 
commonly stored in fetal bovine serum (FBS) plus 10% DMSO 
or growth medium containing serum plus 10%DMSO. Herein we 
have explored two practical aspects of cryopreserving cultured 
mammalian cells during routine laboratory maintenance. First, we 
have examined the possibility of using a serum-free, hence more 
affordable, cryopreservative. Lim et al. (7) have preserved bovine 
oocytes for 2-3 weeks in a serum-free PBS/DMSO 
cryopreservative, and Hubel et al. have employed a PBS/DMSO 
cryopreservative for short term cryo-studies of B lymphoblasts 
(8). We hypothesized that phosphate buffered saline (PBS) 
containing 10% DMSO would effectively preserve a variety of 
mammalian cell lines. To test this, we compared recovery of five 
cell lines after 30 days storage in either FBS+10%DMSO, 
RPMI1640+10%DMSO, or PBS+10%DMSO. 
 
Second, we compared cryostorage of those same cells in 
suspended versus a pellet form in both aforementioned 
cryopreservatives. It has been reported that cell to cell contact 
influences survival during cryo-storage (9-11). In particular, 
membrane integrity of monolayered Chinese Hamster fibroblasts 
cells was more resistant to intracellular ice formation than that of 
non-monolayered controls (9, 10). While we do not expect the 
cells packed in a pellet to be gap- or tight-junctioned, we 
predicted that the packing of cells into a pellet would influence 
both the rate and extent of of intracellular ice formation, Corsini et al.    
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promoting cell survival. In addition, we also predicted that that 
the damage caused by ion partitioning (occurring during 
formation of the H2O crystal lattice) would be mitigated if cells 
were tightly packed in a pellet that excluded buffer. To test these 
predictions, we compared five mammalian cell lines, 
cryopreserved as either a pellet or a suspension, in each of the 
three cryopreservatives. 
 
METHODS AND MATERIALS 
 
Figure 1 depicts the basic experiment carried out on each of the 
cell lines. This experiment was repeated three times for each cell 
line. In conducting this basic experiment, NB324K, A72, 
Crandell Feline kidney, MCF-7, and WI 38 cells were grown to 
70%-90% confluency in 25cm2 tissue culture dishes in RPMI1640 
(SIGMA, Sigma – St. Louis, MO, USA) containing 10% FBS 
(SIGMA, Sigma – St. Louis, MO, USA), in the absence of 
antibiotics. They were detached with trypsin/EDTA (SIGMA, St. 
Louis, MO, USA), the trypsin solution removed via 
centrifugation in a 15ml polypropylene conical tube (VWR 
International, West Chester, PA, USA), and then resuspended in 
1 ml of fetal bovine serum (FBS), phosphate buffered saline 
(PBS), or RPMI1640 containing 10% dimethyl-sulfoxide 
(DMSO-SIGMA, St. Louis, MO, USA). Cells cryo-stored in a 
suspended state were immediately placed at -80°C in a foam 
freezer box (18x18x9cm, with wall thickness of 5cm) packed with 
paper towels. Those cryo-stored in a pellet state were first spun 
for 5 minutes at 200xg. Cells were thawed 30-90 days later by 
placing the 15 ml polypropylene conical tubes in a 37°C water 
bath, and then spun at 200xg for 5 minutes. Cryopreservative was 
drained and residual solution removed with sterile transfer pipet 
and cells resuspended in 4mls fresh growth medium (above) 
followed by seeding into 25cm2 flasks. 
 
Fig. 1: Cells were grown to 50-100% confluency in a 25cm2 flask. They were 
next trypsinized, and upon detachment, 3ml of growth medium were added. Cells 
were then split equally into three 15ml conical polycentrifuge tubes, followed by 
centrifugation and removal of trypsin solution. Each pellet was resuspended in 1 
ml of the idicated cryopreservative (each with 10%DMSO: FBS=fetal bovine 
serum, PBS=phosphate-buffered saline, and RPMI = RPMI1640 with 
bicarbonate). One half of the cells from each treatment were removed to a new 
tube and placed in centrifuge to generate a pellet. Pelleted and suspended cells 
were then inserted into a foam box containing paper towels and placed in a -80°C 
freezer. 
 
Cell viability was measured using attachment and subsequent 
‘spreading’ as a readout. Live cells were easily identified by the 
conversion from a spherical morphology in suspension to a 
‘spread’ morphology characteristic for each individual cell line. 
Validation of this scoring method was carried out by monitoring 
cells post attachment. In all treatments for all cell lines, attached 
and spread cells proved viable by dividing themselves. This was 
ascertained by monitoring doubling time over several days. A72 
and WI 38 were observed to double in confluency (substratum 
coverage) after 1-2 days, and, being at lower densities, attached 
NB324K, CRFK, and MCF-7 cells were located within hand-
marked circular fields and observed to double within 1-3 days. 
This scoring method was used instead of dye exclusion because 
of the possibility that, during freezing and thawing, cells might 
sustain lethal damage to internal membranes but not external 
membranes; such cells would exclude dye and be scored as viable 
when in fact they were dead. Within 18-24 hours after seeding, 
flasks were rocked briefly to resuspend dead cells. Relative cell 
recovery (viability) for each treatment was then estimated by 
determining the average number (5 replicate windows) of 
attached and spread cells in a window at 100x. 
 
We evaluated the resulting data with two approaches. Firstly, we 
compared the relative performance of PBS and RPMI treatment 
to that of the FBS treatment by calculating, for each replication, 
the ratio of recovered cells in either the PBS or the RPMI1640 
treatment to that in the FBS treatment. The estimator of the 
population ratio r is 
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The individual ratios for each rep were then averaged to obtain a 
mean ratio for the three reps, and the accompanying pooled 
standard error, Sp, was calculated for three replications and five 
observations per replication 
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These ratios were calculated for cells cryo-stored in both the 
suspended and the pellet state, and the two states compared 
using a t-test. These results are presented in Table 1. Secondly, 
for each cell line we calculated the weighted mean and pooled 
standard deviation of cells recovered from each of the three 
repetitions for each cryopreservative, in either the suspended or 
the pellet state. For each cell line we then compared recovery in 
the three cryopreservatives using analysis of variance (ANOVA). 
If ANOVA indicated a significant difference in means, Fisher’s 
least significant difference (LSD) statistic was calculated. LSD is a 
comparison criterion used to determine where differences in 
means occur. We also compared recovery in each 
cryopreservative in the suspended state to that in the pellet state 
using the standard t-test. These results are summarized in Table 
2. 
 
RESULTS 
 
Crandell Feline Kidney (CRFK) cells were isolated from the 
kidney of a domestic cat (12-14).  
 
Suspended: The mean ratio of suspended cells surviving in PBS 
or RPMI treatment to those surviving FBS treatment are shown 
in Table 1. According to the ratios, cells in the suspended state 
the PBS preservatives appear to perform somewhat less 
efficiently than the RPMI and the FBS treatments.  However, the 
F statistic generated from the mean number of cells recovered 
from each treatment suggests that these differences are not likely 
to be real (Table 2). 
 
Pellet: The mean ratio of pelleted cells surviving in PBS or RPMI 
treatment to those surviving FBS treatment are shown in Table 1. 
Both serum-free media perform somewhat less efficiently than 
the FBS preservative, with the RPMI1640 cryopreservative 
supporting recovery at 0.5x that of the FBS preservative in the 
pellet state. The F statistic generated from the means of each 
cryopreservative in the pellet state suggests that these differences 
in ratios can be attributed to a large sampling variance rather than 
real differences between the preservatives (Table 2). 
 
Suspended vs. Pellet: A t-test comparing the ratios of RPMI/FBS 
in pellet vs. suspension indicates that there is significant 
difference between relative recovery of RPMI-preserved cells 
stored a suspended or a pellet state (pellet state were recovered at 
0.65x relative to those in suspended state). While this suggests 
that CRFK cells were recovered less efficiently from the pellet 
state if stored in RPMI, t-tests on the mean cell number 
recovered from each state suggests that there is no significant 
difference between recovery of cells from the RPMI preservative 
in either state. The t-tests on mean cell number also suggest that 
CRFK were more effectively (1.8-fold) recovered from the PBS 
cryopreservative when stored in a pellet form (Table 2). 
 
MCF7 (15) is a human mammary epithelial line derived from a 
metastatic site.  
 
Suspended: The mean ratio of suspended cells surviving in PBS 
or RPMI treatment to those surviving FBS treatment are shown 
in Table 1. The observed serum-free to FBS ratios were all within 
25% of 1, and the F statistic generated from the mean number of 
cells recovered from the three cryopreservatives shows a 
significant difference only between the PBS and the FBS 
cryopreservatives. The difference amounts to 0.58x cells 
recovered from recovered from PBS versus FBS 
cryopreservative.  
 
Pellet: The mean ratio of pelleted cells surviving in PBS or RPMI 
treatment to those surviving FBS treatment are shown in Table 1. 
The ratios of cells recovered from serum-free to those from the 
FBS cryopreservative are within 25% of 1, with the RPMI 
preservative slightly outperforming the FBS preservative. 
However, the F statistic generated from the means of the cells 
recovered from the three cryopreservatives suggests that there is 
no significant difference between the cryopreservatives if MCF7 
cells are stored in the pelleted state. 
 
Suspended vs. Pellet: t-tests indicate that pelleting cells had no 
influence on the PBS/FBS or the RPMI/FBS ratios, suggesting 
that all of the cryopreservatives performed equally in either the 
suspended or pelleted state (Table 1). t-tests comparing means 
number of cells recovered from each cryopreservative in each 
state also indicates that the suspension state (suspended or 
pelleted) does not influence recovery of MCF7 cells (Table 2).  
  
A72  cells were derived from a canine fibroma and have been 
utilized in studies of canine parvovirus infection (13-14, 16-17). 
 
Suspended: The mean ratio of suspended cells surviving in 
serum-free treatment to those surviving FBS treatment are shown 
in Table 1. These ratios indicate that both serum-free 
preservatives supported somewhat less recovery than the FBS 
preservative (both within 20% of 1), but ANOVA with the 
means of the cells recovered from the three cryopreservatives 
suggests that there is no significant difference between the 
cryopreservatives with cells stored in the suspended state. 
 
Pellet: The mean ratio of pelleted cells surviving in serum-free 
treatment to those surviving FBS treatment are shown in Table 1. 
Both serum-free preservatives supported somewhat less recovery 
than the FBS preservative, and the LSD statistic generated from 
the means of the cells recovered from the three cryopreservatives 
suggests that recovery from the RPMI preservative promotes 
recovery of pelleted A72 cells at 0.76x that of FBS preservative.  
 
Suspended vs. Pellet: A t-test suggests that pelleting cells had no 
influence on the PBS/FBS ratio (Table 1), suggesting that the 
suspension state does not influence the relative recovery of cells 
in these two preservatives. A t-test also suggests that the 
RPMI/FBS recovery ratio was 0.8x in the pellet state vs. in the 
suspended state. t-tests comparing mean numbers of recovered Corsini et al.    
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cells for each each cryopreservative (in each state) suggest that 
the suspension state (suspended or pelleted) does not influence 
recovery of A72 cells stored in either PBS or FBS 
cryopreservatives, but that A72 in RPMI in the suspended state 
were recovered 1.47x more efficiently than those in pellet state 
(Table 2). These results indicate efficient recovery of A72 in 
serum free cryopreservatives from either the pelleted or the 
suspended state. 
 
NB324K is an SV/40 transformed human kidney cell line (18-
20).   
 
Suspended: The mean ratio of cells surviving in the two serum-
free treatments, PBS or RPMI based, to those surviving FBS 
treatment are shown in Table 1. Both serum-free 
cryopreservatives supported only half the recovery of the FBS 
preservative, but the LSD statistic on mean number of recovered 
cells suggests that only the difference between the PBS and FBS 
treatments is real (Table 2). This difference is 0.60x cells 
recovered from the PBS versus the FBS treatment.  
 
Pellet: The mean ratio of cells surviving in serum-free treatment 
to those surviving FBS treatment are shown in Table 1. Ratios 
indicate somewhat lower recovery from the serum-free 
preservatives with cells stored in a pelleted state. However, the 
LSD statistic from mean number of NB324K cells recovered 
from the three cryopreservatives indicate that the RPMI 
treatment likely supported a 1.3x higher rate of recovery than 
either the PBS or the FBS preservatives (Table 2) when these 
cells were stored in a pellet state. 
  
Suspended vs. Pellet: t-tests indicate that the ratio of recovered 
cells for PBS/FBS and RPMI/FBS is 1.3x higher with cells 
stored in the pellet state. Comparisons of the mean number of 
recovered cells (Table 2) reveals that cells stored in PBS 
preservative were recovered with 1.4x greater efficiency in the 
pellet state. Those in the RPMI preservative were recovered with 
1.5x greater efficiency in the pellet state. These results indicate 
that the serum-free preservatives were slightly more effective at 
preserving pelleted NB324K cells (versus suspended cells) in a 
frozen state. 
 
WI 38 is a human diploid fibroblast line with a finite life of 
50+/-10 divisions (21-23), that has been utilized in production of 
poliovirus vaccine (22). These cells arose from a primary explant 
of human fetal lung tissue, the chromosomes are considered 
normal, and the cells have undergone no known transformation 
events. 
 
Suspended: The mean ratio of suspended cells surviving in PBS 
or RPMI treatment to those surviving FBS treatment are shown 
in Table 1. According to the ratios, both serum free preservatives 
appear to perform somewhat less efficiently than the FBS 
treatment with cells in the suspended state. The F statistic 
generated from the mean number of cells recovered from each 
treatment suggests that the PBS treatment truly did not support 
recovery as well as did the FBS or RPMI-based preservatives. 
 
Pellet: The mean ratio of pelleted cells surviving in PBS or RPMI 
treatment to those surviving FBS treatment are shown in Table 1. 
Both serum-free media perform approximately 0.60x less 
efficiently than the FBS preservative. The F statistic generated 
from the means of each cryopreservative in the pellet state 
suggests that these differences in ratios are real (Table 2). 
 
Suspended vs. Pellet: A t-test indicates that there is a significant 
difference in the ratio of cells recovered from serum-free versus 
serum containing after storage in a pellet versus a suspended state 
(Table 1). Analysis of the mean number of recovered cells shows 
that for the FBS treatment, WI 38 cells stored in a pellet state 
were recovered at 0.67x relative to those in suspended state, and 
those from the RPMI cryopreservative in pellet state were 
recovered at 0.48x relative to those in suspended state (Table 2). 
 
DISCUSSION 
 
Based upon the PBS/FBS and RPMI/FBS ratios, it appears that 
in most cases survival in the serum-free preservatives is 
somewhat lower than that in serum-containing conditions. The 
largest lowering observed was a halving of the recovery rate, 
which occurred in two cases: NB324K in RPMI1640 preservative 
in the suspended state and CRFK in RPMI preservative in the 
pellet state (see Table 2). In some cases, the serum-free 
preservatives performed somewhat better than the serum-
containing counterpart. In general, we feel that the differences we 
observed are of no practical consequence when cryostoring cells 
during routine maintenance because typically millions of cells are 
frozen during these procedures. In laboratories that store large 
volumes of cultured cells, this ability to eliminate expensive 
serum from cryopreserving solutions may represent a significant 
cash savings. Collectively, the data also indicate that there are not 
large differences in recovery rate of cells stored in pellet versus 
suspended form. This suggests that packing the cells together did 
not influence damage due to ice crystal formation or osmotic 
stresses. We note, however, we were working with fairly low 
numbers of cells that produced pellets on the order of 0.1-0.5 
mm3, and it is possible that the above predictions would not 
manifest themselves until the packing volume reached an as yet 
undetermined threshold.  
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TABLES 
 
Table 1: Comparison of cell recovery in phosphate-buffered saline or RPMI1640 based cryopreservative with recovery after storage in fetal bovine serum 
based cryopreservative.  
Cell Line  PBS/FBS 
suspended 
PBS/FBS 
pellet  t -test  RPMI/FBS 
suspended 
RPMI/FBS 
pellet  t-test 
Crandell Feline 
Kidney 
0.62 sp =0.25  0.79 sp  =0.35  t=1.53 
P=0.137 
0.75 sp = 0.38  0.49 sp =0.21  t=2.32 
P=0.028 ** 
MCF7 0.84  sp =0.34  0.90 sp =0.38   t=0.46 
P=0.652 
0.92 sp =0.29   1.25  sp =0.85  t=1.42 
P=0.166 
A72 0.79  sp =0.15  0.76 sp =0.13  t=0.58 
P=0.563 
0.87 sp =0.14  0.67 sp =0.09  t=4.65 
P=0.000 ** 
NB324K 0.58  sp =0.12  0.75  sp =0.21    t=2.72 
P=0.011 * 
0.50 sp =0.07  0.64 sp =0.09  t=3.88 
P=0.001 ** 
WI 38  0.65 sp =0.10  0.62 sp =0.22  t=0.48 
P=0.634 
0.87 sp =0.13  0.61 sp =0.18  t=4.54 
P=0.000** 
Storage was carried out in either a suspended or a pellet state. Shown is a weighted mean and pooled standard error of the ratio of recovered cells in PBS/10%DMSO or 
RPMI1640/10%DMSO treatment to the same in accompanying FBS/10%DMSO treatment. Recovery was scored by counting five windows at 100x and then averaging 
for each rep. The weighted mean was calculated based on data from three repetitions for all treatments with all lines except for the RPMI/FBS ratio of NB324K, which is 
the average of two repetitions. sp is the pooled standard error of the replications. The t-tests are two tailed. *significant at the 0.05 level. **significant at the 0.01 level.        
 
Table 2: The weighted mean of three reps for each treatment in each state. 
Treatment Suspension  Pellet  t-test 
suspension vs pellet 
FBS/10%DMSO(1) 
 
CRFK            66 sP =38 
 
MCF7           12 sP = 7 
 
A72              234 sP =69 
 
NB324K        83 sP =26 
 
WI 38            29  sP  =9     
CRFK       89  sP =54 
 
MCF7         8  sP =  4 
 
A72         191  sP =58 
 
NB324K   76  sP =22 
 
WI 38        20   sP = 4               
t=1.35     p=0.188 
 
t=1.92     p=0.065 
 
t=1.85     p=0.075 
 
t=0.79     p=0.433 
 
t= 3.544  p=0.001** 
PBS/10%DMSO(2)  CRFK            40 sP =11 
 
MCF7              7 sP =  2 
 
A72              190 sP =49 
 
NB324K       50  sP =31 
 
WI 38            16  sP = 5     
CRFK      75  sP =16  
 
MCF7        8  sP =  3 
 
A72        160  sP =37 
 
NB324K   72  sP =26 
 
WI 38        12  sP = 8     
t=6.98     p=0.000  ** 
 
t=1.07     p=0.292 
 
t=1.89     p=0.069 
 
t=2.10     p=0.044    *  
 
t=1.64     p=0.112  
RPMI1640/10%DMSO(3)  CRFK           69  sP =73 
 
MCF7           10  sP =  4 
 
A72              213  sP =31 
 
NB324K        65 sP =14 
 
WI 38            25  sP = 6     
CRFK       70  sP =55 
 
MCF7       10  sP =  5 
 
A72        145  sP =29 
 
NB324K    95  sP =19 
 
WI 38        12  sP = 6 
t=0.00     p=0.967 
 
t=0.00     p=1.000 
 
t=6.20     p=0.000  ** 
 
t=4.92     p=0.000  ** 
 
t=5.93    p=0.000   ** 
ANOVA 
FBS vs PBS vs RPMI 
CRFK      F=1.66,  P=0.202 
MCF7      F=4.13,  P=0.023,LSD=3.5* 
A72          F=2.68,  P=0.080 
NB324K F=6.70,P=0.003,LSD=18.2** 
WI 38  F=14.05,P=0.000,LSD=5.07** 
  F=0.7,  P=0.5 
  F=1.2,  P=0.3 
  F=4.4,  P=0.02,   LSD=31.8* 
  F=4.5,  P=0.02,   LSD=16.6 *  
 F=8.28, P=0.001, LSD=4.58  **                
 
The mean is followed by sP, the pooled standard deviation of the three reps. The t-tests are two tailed with 28 degrees of freedom. Analysis of Variance: The critical F 
value = 3.22 for α =0.05 and 2, 42 degrees of freedom. LSD=Fisher’s least significant difference for α =0.05. The critical F value = 5.15 for α = 0.01 and 2, 42 degrees of 
freedom.*significant at the 0.05 level. **significant at the 0.01 level. 
 